Respiri Limited Price Chart
Respiri Limited RSH.XA Financial and Trading Overview
| Respiri Limited stock price | 0.02 AUD |
| Previous Close | 0.04 AUD |
| Open | 0.04 AUD |
| Bid | 0.04 AUD x N/A |
| Ask | 0.04 AUD x N/A |
| Day's Range | 0.04 - 0.04 AUD |
| 52 Week Range | 0.03 - 0.08 AUD |
| Volume | 135 AUD |
| Avg. Volume | 44.35K AUD |
| Market Cap | N/A |
| Beta (5Y Monthly) | -0.209961 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.011 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
RSH.XA Valuation Measures
| Enterprise Value | 29.51M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 12.333333 |
| Enterprise Value/Revenue | 41.539 |
| Enterprise Value/EBITDA | -4.798 |
Trading Information
Respiri Limited Stock Price History
| Beta (5Y Monthly) | -0.209961 |
| 52-Week Change | -9.75% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.08 AUD |
| 52 Week Low | 0.03 AUD |
| 50-Day Moving Average | 0.05 AUD |
| 200-Day Moving Average | 0.05 AUD |
RSH.XA Share Statistics
| Avg. Volume (3 month) | 44.35K AUD |
| Avg. Daily Volume (10-Days) | 48.39K AUD |
| Shares Outstanding | N/A |
| Float | 658.55M |
| Short Ratio | N/A |
| % Held by Insiders | 19.60% |
| % Held by Institutions | 4.38% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -867.69% |
| Gross Margin | 58.29% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -77.36% |
| Return on Equity (ttm) | -175.35% |
Income Statement
| Revenue (ttm) | 710.37K AUD |
| Revenue Per Share (ttm) | 0.001 AUD |
| Quarterly Revenue Growth (yoy) | -9.40% |
| Gross Profit (ttm) | 512.9K AUD |
| EBITDA | -6149839 AUD |
| Net Income Avi to Common (ttm) | -6155680 AUD |
| Diluted EPS (ttm) | -0.011 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 230.07K AUD |
| Total Cash Per Share (mrq) | 0 AUD |
| Total Debt (mrq) | 0 AUD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 3.064 |
| Book Value Per Share (mrq) | 0.003 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -8183487 AUD |
| Levered Free Cash Flow (ttm) | -5752254 AUD |
Profile of Respiri Limited
| Country | Australia |
| State | VIC |
| City | Melbourne |
| Address | 432 St Kilda Road |
| ZIP | 3004 |
| Phone | 61 3 9653 9160 |
| Website | https://respiri.co |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia. The company develops, produces, and sells mobile health applications. Its products include wheezo, an electronic wheeze detection tool to detect wheeze in children; respiri mobile application; and Respiri health portal. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. Respiri Limited is based in Melbourne, Australia.
Q&A For Respiri Limited Stock
What is a current RSH.XA stock price?
Respiri Limited RSH.XA stock price today per share is 0.02 AUD.
How to purchase Respiri Limited stock?
You can buy RSH.XA shares on the Cboe AU exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Respiri Limited?
The stock symbol or ticker of Respiri Limited is RSH.XA.
How many shares does Respiri Limited have in circulation?
The max supply of Respiri Limited shares is 0.
What is Respiri Limited Price to Earnings Ratio (PE Ratio)?
Respiri Limited PE Ratio is now.
What was Respiri Limited earnings per share over the trailing 12 months (TTM)?
Respiri Limited EPS is -0.011 AUD over the trailing 12 months.